The risks from potential exposure to COVID-19 and resource reallocation that has occurred to combat the pandemic have altered the balance of benefits and harms that informed current pre-COVID-19 guideline recommendations for lung cancer screening and lung nodule evaluation. We developed consensus statements to guide clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.